Transcript Highlights:

• We touched base with FDA, and we made the determination. food regulations.
• We touched base with FDA, and we made the determination late last week that we can, in fact, regulate
• It's considered an adulterant by FDA, which means it can't be added to food or drink products.
• Chair, and Senator Treheel, cratim under the FDA is a prohibited added.
• So, kratom under the FDA is a prohibited additive in any type of health additive, health product.

Summary: The committee first recognized Mark Roper of the Economic Development Department for his long service and retirement, with members and the secretary praising his work on economic development across the state. Secretary Rob Black then presented EDD’s budget and special appropriation requests, describing strong recent job and income growth and outlining the department’s strategy around science and technology, site readiness, workforce development, foreign direct investment, and rural/community programs. He highlighted wins in advanced energy, quantum, space and defense, and biosciences, and asked for funding for quantum/DARPA matching funds, additional site readiness work, LIDA closing funds, JTIP training support, New Mexico Partnership, and healthy foods and other community programs. Members asked detailed questions about the quantum proposal, site readiness, the new mapping tool for industrial sites, workforce participation, trade missions, foreign investment, tariffs, water and produced water, tribal site evaluation, and public engagement on major projects. Black said the quantum request was intended to match federal dollars and build a workforce pipeline, that the site-readiness software would be a set enterprise license, and that the department was working with tribes and local partners on future site evaluations. He also said tariffs have created uncertainty but New Mexico’s infrastructure and foreign trade zones could help attract manufacturing, and he acknowledged concerns about transparency and community input while noting that some projects, such as Pacific Fusion, had gone through extensive public processes. The committee also discussed specific projects and funding balances, including Mantis Space’s move to Albuquerque, the status of Virgin Galactic’s spaceport lease, and the current LIDA fund balance and encumbrances. Black and Deputy Secretary Isaac Romero said the department was trying to use State Investment Council-backed venture funds to attract companies and that the new investments were already producing deals and jobs. Members generally supported the department’s direction but pressed for more targeted expertise, faster deployment, and stronger community involvement in future economic development decisions. Later, Secretary de Blassie of the Department of Health presented the department’s budget request and progress report. He said DOH had improved revenue cycle management, reduced old Medicaid-pending cases, increased census at facilities, improved budget and contract timeliness, and responded effectively to the measles outbreak. The department requested additional base funding for epidemiology and response, the DOH helpline, the Vital Records Virtual Vault, state labs, and the veterans home, along with special requests for respiratory vaccinations and marketing and lab equipment replacement. He also noted progress on MOUD and the medical psilocybin program, and said the department was not seeking to launch new programs given the limited time left in the administration.

Transcript Highlights:

• Time after time, patients who exercised informed consent about the use of FDA-approved treatment such
• are in a country where there's a right to try, and as long as a medication has been approved by the FDA
• are in a country where there's a right to try, and as long as a medication has been approved by the FDA
• We weren't trained, okay, you can only prescribe a medication if it's indicated for use by the FDA.
• They're using the FDA as an excuse to block prescriptions. Thank you. Senator Hull?

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Summary: The committee heard testimony on Senate Bill 883, which would protect physicians’ ability to prescribe off-label medications and treatments, framed by the author as a “Right to Treat” measure tied to COVID-19 care. Supporters, including physicians and patient-choice advocates, said the bill would safeguard the doctor-patient relationship and prevent interference by boards, pharmacies, or hospitals. Several witnesses described using hydroxychloroquine, ivermectin, budesonide, antibiotics, steroids, and monoclonal antibodies during the pandemic, and said they faced complaints, board scrutiny, or pharmacy refusals for those prescriptions. The bill was left pending after public testimony closed. The committee then took up Senate Bill 331, which would extend hospital price-transparency requirements to additional health care facilities such as freestanding ERs, urgent care and retail clinics, ambulatory surgical centers, outpatient clinics, and birthing centers. Proponents argued that broader disclosure of prices for shoppable services would help consumers compare costs and reduce surprise billing, while opponents from ambulatory surgery centers said the bill would impose costly compliance burdens on small providers and that insurers or the state already have much of the needed data. The bill was also left pending. Senate Bill 2422 would expunge Texas Medical Board records and impose reparations for disciplinary actions tied to COVID-era treatment decisions, including references to ivermectin, hydroxychloroquine, budesonide, and masks. The author and supporters argued that doctors were unfairly targeted for trying to save patients and should be made whole; the Texas Medical Board representative said most pandemic complaints were dismissed, that actions generally involved broader issues such as privileges, documentation, or informed consent, and that no physician was disciplined solely for prescribing off-label COVID medications. The bill was left pending. Finally, the committee heard Senate Bill 2207, which would loosen Texas Medical Board rules on physicians advertising themselves as board certified, especially by reducing barriers tied to maintenance of certification requirements. Supporters said the current rule is overly restrictive, inconsistent, and costly, and that it drives physicians out of practice; they also said Texas is one of only a few states with such a rule. Witnesses described hospitals using the rule against physicians and said the change would improve transparency and competition. The bill remained pending after testimony.

Transcript Highlights:

• There are reported deaths, even by the FDA, which has the weakest, most lax reporting requirements—deaths
• None of that's required by the FDA.

Bills: HCR35, SJR59, SJR84, SCR30, SB127, SB317, SB324, SB457, SB506, SB511, SB529, SB547, SB584, SB619, SB636, SB646, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB904, SB1026, SB1049, SB1065, SB1181, SB1224, SB1250, SB1383, SB1467, SB1524, SB1528, SB1531, SB1568, SB1585, SB1640, SB1681, SB1754, SB1757, SB1777, SB1972, SB1980, SB2007, SB2041, SB2046, SB2050, SB2055, SB2069, SB2080, SB2119, SB2138, SB2139, SB2154, SB2201, SB2225, SB2268, SB2306, SB2308, SB2310, SB2330, SB2366, SB2375, SB2392, SB2401, SB2422, SB2480, SB2514, SB2530, SB2533, SB2543, SB2544, SB2589, SB2610, SB2615, SB2623, SB2660, SB2662, SB2693, SB2695, SB2707, SB2722, SB2742, SB2753, SB2807, SB2843, SB2844, SB2858, SB2880, SB2885, SB2891, SB2925, SB2938, SB2986, SJR3, SJR18, SB5, SB914, SB963, SB1197, SB1415, SB1437, SB1786, SB326, SB767, SB769, SB783, SB1035, SB1271, SB1619, SB1637, SB1806, SB1, SB260, HB135, HB1109, HCR35, HCR64, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR48, SCR19, SCR30, SCR3, SB2023, SB619, SB2742, SB646, SB1026, SB2880, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB584, SB1085, SB2046, SB1975, SB2717, SB1262, SB1524, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB1721, SB2366, SB1013, SB2797, SB2383, SB1754, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2929, SB1972, SB2540, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB506, SB2514, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB410, SB659, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586, HB1392, HB22, SB1551, SB3039, SB2819, SB66, SB629, SB1015, SB2342, SB2903, SB2933, SB1965, SB2477, SB3029, SB2605, SB2419, SB1957, SB375, SB250, SB777, SB628, SB2523, SB2367, SB2703, SB2608, SB2778, SB3044, SB2965, SB2521, SB865

Keywords: spaceports, tax-exempt bonds, aerospace investment, Texas space economy, Federal legislation, education funding, Texas State Technical College System, capital projects, infrastructure, higher education, tax exemption, property tax, homestead, fire damage, constitutional amendment, Birding Capital, Matagorda County, wildlife, conservation, Texas Legislature

Transcript Highlights:

• What we're trying to do is align the FDA standards with the FDA standards.

Bills: HB294, HB405, HB519, HB294

Keywords: food production, property owners' association, home gardening, cottage food, urban agriculture, livestock, community standards, renewable energy, ethanol, biodiesel, incentives, agriculture, grants, honey production, beekeeping, food safety, local regulation, energy efficiency, tax exemption, residential properties

Transcript Highlights:

• By the EPA or the FDA. Many of these products are registered before we had an EPA.
• Isoxyacetyl exoseline products that are now gaining registrations by the FDA, which has been very...
• We fall under FDA and EPA, two very different federal agencies.
• And what a veterinarian is allowed to use off-label falls typically under FDA, whereas EPA is more strict
• to work together to leverage all of the different authorities that are out there, whether it's EPA FDA

Summary: During the meeting, legislative members discussed the practice of municipalities diverting water and sewer revenues to their general funds, which impacts infrastructure maintenance and project delays. Vice Chair Sparks proposed limiting public testimony to two minutes, which was adopted without objection. The committee heard from various witnesses, including Perry Fowler from the Texas Water Infrastructure Network, who emphasized that utility revenues should primarily support water services and that transfers should be transparent and justified. He noted that many utilities face financial pressures that could hinder infrastructure projects. Larry French from the Texas Public Policy Foundation highlighted the significant financial impact of water loss and general fund transfers, estimating the annual loss at $1.5 billion. He argued that these transfers can create disincentives for municipalities to address water loss issues. Brian Butcher, Assistant City Manager of Sugar Land, defended the city's cost allocation model for general fund transfers, asserting that they are necessary for equitable service provision and operational efficiency. The committee also discussed the implications of rising construction costs and the need for better procurement processes to ensure effective use of taxpayer dollars. The second part of the meeting focused on the New World Screwworm and the state's preparedness to manage potential infestations. Dudley Hoskins from the USDA outlined the federal response efforts and the importance of collaboration with state agencies. He emphasized the need for ongoing surveillance and the production of sterile flies to combat the pest. Dr. Philip Kaufman from Texas A&M discussed the historical context of the screwworm and the challenges posed by its potential reintroduction, urging proactive management strategies among livestock producers. The committee acknowledged the need for increased resources and research to effectively address the threat of the screwworm.

Transcript Highlights:

• prohibiting prior authorization or step therapy by applying these protections to all drugs approved by the FDA
• It also recognizes that By the FDA or recommended by the CDC.
• Nearly all of the medications we recommend are FDA-approved and all are known to be effective to treat
• bunch of other medications I’m willing to talk about, but one other one is Vosa, which was recently FDA
• review and approve all research studies on Schedule I and II controlled substances once they receive FDA

Summary: The Assembly Health Committee heard a long agenda of health bills focused on access to preventive care, behavioral health, hospital services, and patient safety. Early items included AB 554, which would expand and protect access to HIV prevention drugs like PrEP, including injectable forms and coverage protections; supporters said it would shore up access amid federal threats, while insurers opposed it as a costly benefit mandate. AB 577 would limit insurer and PBM practices that steer medications away from physician offices and require more transparency and patient consent; doctors and patient advocates supported it, while health plans and insurers warned it could raise drug costs and disrupt specialty pharmacy networks. AB 546 would require coverage for portable HEPA purifiers for vulnerable enrollees during declared emergencies, especially wildfire smoke events, with support from air quality and public health groups and opposition from insurers concerned about benefit expansion and cost. The committee also heard AB 224, which would codify California’s updated essential health benefits benchmark plan after a public review process, adding infertility treatment, hearing aids, and durable medical equipment if approved by CMS for the 2027 plan year. DMHC said the state had completed the review and needed legislation to meet federal timing, and the measure drew broad support. AB 1032 would require plans and insurers to reimburse up to 12 additional behavioral health visits for enrollees in wildfire-affected counties for a limited period after an emergency; supporters argued it would fill gaps in trauma care after disasters, while insurers said existing parity and continuity-of-care rules already address the issue and that the bill could create inequities. AB 849 would require trained chaperones for sensitive ultrasound exams and training on how to observe and intervene; it was backed by a survivor and patient advocates, with hospitals and health districts raising staffing concerns. Later, AB 1196 would direct the Department of Public Health to update outdated rules requiring three surgeons for certain heart surgeries using cardiopulmonary bypass; supporters said the rule no longer reflects modern practice and strains staffing, while cardiology representatives had no formal opposition but wanted to review amendments. AB 1113 would codify a right to wear a mask for health reasons in public spaces, with support from disability and public health groups. AB 1386 sought to add perinatal care to the list of basic hospital services, prompting testimony about maternity ward closures, workforce shortages, and rural access; the author said the bill would be amended further and that the committee would need to revisit timelines and implementation details. The committee also heard AB 1429, which would address Kaiser’s repeated mental health parity violations and improve access to behavioral health care, though the transcript cuts off before any action on that bill is shown. Several bills were moved with motions and seconds, but many were held for quorum; AB 1196, AB 1113, and AB 1386 were among the measures advanced to a roll call or held on call, and the committee repeatedly noted that final votes would occur when quorum was available.

Bills: SB25, SB250, HB22, HB27, HB33, HB47, HB233, HB290, HB308, HB324, HB382, HB533, HB559, HB575, HB980, HB1157, HB1207, HB1236, HCR45

Keywords: registrar of voters, parish registrar, chief deputy registrar, confidential assistant, election administration, elections, salary schedule, compensation, merit evaluation, population-based pay, census-based pay, Department of State, Secretary of State, State Board of Election Supervisors, redistricting, senate districts, Senate District 33, Senate District 34, Senate District 35, precincts

Transcript Highlights:

• We just want to facilitate the speedier process of FDA clinical trials.
• We also understand that it's going to be a 10-year process for these FDA clinical trials.

Bills: HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647

Keywords: dentistry, licensing, dental hygiene, foreign-trained dentists, temporary license, public health, emergency response, child care, workforce, pilot program, affordable care, income eligibility, interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation

Transcript Highlights:

• their risk of loss increasing their risk of osteoporosis<00:40:21.400> the<00:40:21.520> FDA
• c><00:40:22.079> recently<00:40:22.680> added<00:40:22.920> a osteoporosis the FDA
• recently added a osteoporosis the FDA recently added a warning<00:40:23.480> that<00:40:23.680
• so you're looking approved by the FDA so you're looking and<01:03:50.000> trying<01:03:50.200
• blocker that is approved by the FDA blocker that is approved by the FDA under<02:05:33.559> that

Keywords: 1189, house, all

Transcript Highlights:

• um you know, warnings from the the FDA um you know, warnings from the the FDA about<04:00:29.520
• The FDA does regulate vaping devices under the Tobacco Control Act.
• /c><04:25:29.920> data lot of that back. and the FDA has data lot of that back. and the FDA has
• Um, but the FDA has a list of e-cigarettes that are authorized by the department.
• Um, but the FDA has a list of one copy.

Keywords: 928, house, all

Summary: The hearing focused on House Bill 1281, which would establish standards and voluntary certification for agency-owned “facility comfort dogs” used by police and other public safety agencies. Representative Morton, the prime sponsor, said the bill is intended to create a consistent statewide framework because different departments currently use different policies. He emphasized that the bill is meant to distinguish comfort dogs from service animals, emotional support animals, and therapy dogs, and noted that a small amendment may be needed to make that distinction clearer. He also said the bill is timely under the ADA because comfort dogs fall outside service-animal protections, but still need training standards for public safety and consistency. Committee members questioned whether the bill was too detailed and whether the legislature should be setting rules on matters like training methods, diet, and breeding. Laura Barker of Hero Pups, who helped train New Hampshire’s first police comfort dog, supported the idea of a minimum standard but said the bill should be less prescriptive and should not interfere with therapy dogs or private handlers. She explained that comfort dogs vary in temperament and deployment needs, that raw diets raise zoonotic disease concerns, and that the program should remain voluntary and not cost the state money. Detective Michelle Jones of Portsmouth Police opposed the bill as written, saying the term “facility comfort dog” is confusing, the bill is overly restrictive, and some provisions go beyond what should be mandated by statute; she suggested a more flexible, guideline-based approach and noted that departments already have their own SOPs and can enforce them internally. Justin Brassen of the Manchester Police Department also testified, describing the history of comfort dog programs in New Hampshire and the work of a prior subcommittee formed through the governor’s commission on PTSD among first responders. He said there are currently no statewide standards and that the earlier study involved police, fire, EMS, dispatch, corrections, and NAMI New Hampshire, with the goal of creating a thoughtful work product. He agreed the bill needs work and answered questions about how departments handle training and public access. By the end of the hearing, members and witnesses discussed possible amendments, and one committee member suggested the bill may be better handled through interim study because of the amount of work still needed.

Transcript Highlights:

• and in this time frame, we hired a recall coordinator who has had quite a bit of experience with the FDA
• Which is very normal in FDA recalls that have been happening for centuries or decades at least.

Keywords: 914, all

Transcript Highlights:

• VALDES BECAUSE THIS ALLOWS MUNICIPAL STATE AGENCY APPROVED BY FDA LEAD TO PROVIDE GUARDIAN TRAINING FOR
• PROVIDING TRAINING INTO EXISTING REQUIREMENTS RELATED TO CERTIFYING THE INDIVIDUAL AND PROVIDING RECORDS TO FDA

Transcript Highlights:

• There are reported deaths even by the FDA, which has the weakest, most lax reporting requirements, deaths
• None of that's required by the FDA.

Transcript Highlights:

• This technology allows our faculty to start accomplishing the goals that are set by FDA and other bodies
• This technology allows our faculty to start accomplishing the goals that are set by FDA and other bodies
• that<01:43:43.239> are<01:43:43.400> set<01:43:43.679> by<01:43:43.840> FDA
• <01:43:44.280> and<01:43:44.400> other goals that are set by FDA and other goals that
• are set by FDA and other bodies<01:43:45.080> in<01:43:45.199> order<01:43:45.400>

Keywords: 1187, senate, all

Transcript Highlights:

• That’s thanks to science-based oversight by the FDA.
• Banning FDA-approved ingredients will make it harder for schools to offer affordable, nutritious, and
• So I understand your argument is that, you know, we have federal FDA and USDA guidelines for schools
• So I understand your argument is that, you know, we have federal FDA and USDA guidelines for schools
• And we trust the FDA and its science-based approach.

Keywords: 995, all

Summary: The Joint Committee on Education held a public hearing on a large slate of bills, with the chairs emphasizing time limits, written testimony, and grouping similar measures together. Early testimony focused on opioid use disorder education in schools (S.382), with Senator Keenan arguing that students should be taught about the risks of substance use disorder and naloxone use as part of health curricula. Representative DeCost also briefly introduced H.551, a narrow bill concerning parent rights for children in third grade and younger. Several bills were then closed without testimony, including measures on type 1 diabetes informational materials and other diabetes-related proposals. A major portion of the hearing centered on school health and emergency response bills. Supporters of H.652/S.342 on diabetes management in schools described inconsistent district practices and urged clearer standards so students can receive care in classrooms rather than being sent out of instruction. Bills on epinephrine access and seizure disorders drew extensive testimony: advocates for stock epinephrine in schools argued that unassigned epinephrine can save lives and should be funded in a cost-neutral way, while a pediatrician opposed one version as an unfunded mandate. For seizure-safe schools (S.422/H.635), students, parents, educators, and advocates described missed or delayed responses to seizures, stigma, and the need for staff training, seizure action plans, and emergency medication protocols. A separate bill, H.645, allowing anti-seizure medication on school buses, was supported by a parent and student who said current law forces costly and restrictive transportation arrangements. The committee also heard testimony on youth skin health bills (S.334/H.600/H.619), which would let students carry and apply sunscreen at school and camp without a physician’s note. Supporters from melanoma prevention, dermatology, and industry groups said the bills would remove unnecessary barriers and promote sun-safe habits, while one witness cautioned about drafting details and unintended consequences. The hearing then moved to CPR/AED education for graduation (S.456), where Senator Tarr, a student advocate, and the Red Cross all supported requiring hands-on CPR certification for high school students. Finally, the committee took testimony on healthy school lunches (H.539/S.401): supporters from the Healthy School Lunch Coalition and school food directors backed stronger nutrition standards and a standing advisory council, while Consumer Brands Association witnesses opposed the bill as too vague and potentially disruptive. A nutrition scientist also warned about unintended restrictions on medically necessary or innovative foods. The chairs closed the hearing on the healthy lunch bills and then opened testimony on universal school meals for virtual schools (H.700), with Superintendent Patrick Latuka supporting access for students in Commonwealth virtual schools who currently receive no meal support.

Transcript Highlights:

• It's a nationwide problem, and the FDA should, um, have taken care of this a long time ago.
• It's a nationwide problem and the<00:39:47.240> FDA<00:39:47.760> should<00:39:48.360><
• 48.640> have<00:39:48.840> taken<00:39:49.080> care<00:39:49.240> of the FDA
• should um have taken care of the FDA should um have taken care of this<00:39:49.960> a<00:39:

Keywords: 1189, house, all

Transcript Highlights:

• Time after time, patients who exercised informed consent about the use of FDA-approved treatments such
• are in a country where there's a right to try, and as long as a medication has been approved by the FDA
• We weren't trained to think you can only prescribe a medication if it's indicated for use by the FDA.
• They're using the FDA as an excuse to block prescriptions. Thank you, ma'am. Dr.

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Transcript Highlights:

• We now feel that with two FDA-approved drugs and most recently an FDA-approved blood test, we know that
• And so how does the medical profession guard against So, news flash, Senator Lopez, there is now an FDA

Transcript Highlights:

• and HHS to please work swiftly the FDA and HHS to please work swiftly in<00:33:05.800> getting
• We're the second lab in the United States to have an FDA-cleared AI for women's health screening. about
• <01:02:17.560> AI<01:02:18.000> for States to have an FDA-cleared AI for States to
• have an FDA-cleared AI for women's<01:02:18.560> health<01:02:18.800> screening.
• And what we brought in-house a year ago is an FDA-approved women's health cancer screening AI module

Keywords: 958, all

Summary: The committee opened its sixth and final interim meeting with roll call, quorum confirmation, approval of the prior minutes, and a brief change in agenda order to preserve quorum and accommodate presenters’ schedules. Members then moved through several proposed health-related items with limited discussion, and the chair noted the committee would reconvene in January for further conversation. The first substantive item was a proposal relating to utilization controls for non-opioid analgesics in Medicaid. Senator Gerald Neal and Tara Hyde of People Advocating Recovery argued that pain parity is needed so patients can access non-opioid options without prior authorization or step therapy barriers, especially in acute pain situations and for people in recovery. Senator Berg supported the concept and suggested expanding the approach to other prescriptions by allowing physicians to explain why step therapy is inappropriate at the time of prescribing; another member cautioned against unintended cost increases if non-opioid drugs are used as add-ons to opioids. The committee then heard a proposal on physician assistants from Senator Scott and Andrew Rutherford of the Kentucky Academy of Physician Assistants. They described a shift from a supervisory to a collaborative practice model, with practice scope set at the practice level, limited Schedule II prescribing authority under guardrails, and permission for PAs to perform driver’s license vision testing. Supporters said the changes would improve rural access, reduce administrative burden, and align Kentucky with neighboring states; a question from Representative Bratcher focused on experience requirements and how the proposal compares with nurse practitioner rules. No vote was taken. Finally, Representative Nancy Tate, Adia Wuchner, and Representative Jason Nemes introduced a 2026 proposal aimed at “protecting vulnerable people.” They described a broad package focused on abortion pill trafficking, marketing to minors, commercial surrogacy, assisted suicide, and organ procurement safeguards, arguing that current law leaves gaps and that additional criminal and civil penalties are needed. The presentation was informational only, with no action taken before the meeting ended.

Transcript Highlights:

• and passed Senate Bill 906, permitting lawful prescription of crystalline polymorph psilocybin under FDA
• Food and Drug Administration approval and is rescheduled by the FDA as being lawful, prescribed, distributed

Keywords: 994, senate, all

Summary: The Senate took up a series of House amendments to enrolled bills and, in each case, moved to concur, pass the bill, and in several instances set effective dates. Measures approved included SB 29 (judiciary pay increases), SB 44 (homemade food/cottage food rules), SB 617 (protections against financial exploitation of eligible adults), SB 742 (involuntary hospitalization requirements), SB 952 (court security fund transfer), SB 1008 (asbestos and silica statute of limitations), SB 723 (law enforcement cooperation with bordering states), SB 947 (birth certificate copies for homeless minors), SB 392 (personal income tax reduction), SB 54 (criminal penalties for abuse or neglect of incapacitated adults), SB 228 (technology in child abuse/neglect investigations, including a three-county caseworker aid pilot), SB 231 (value-based payment requirements), SB 402 (Workforce Readiness Opportunity Act, with the House removing several provisions but retaining a micro-credential program), SB 553 (temporary transfer of contractor licenses to qualifying immediate family members), SB 575 (refusal review hearings), SB 686 (coal code modernization and minors protection), SB 906 (lawful prescription of crystalline polymorph psilocybin under FDA recommendations), SB 1026 (penalties for disturbing religious worship), SB 63 (Sustaining Opportunities for Academics and Rural Schools Act), SB 502 (Women’s Collegiate Sports Protection Act), and SB 153 (Unemployment Automation and Administration Fund). Most of these passed with unanimous or near-unanimous votes; SB 392 passed 31-2 on the first vote and was later reconsidered and passed again 32-2. Several bills were made effective from passage or on July 1, 2026, by the required supermajority votes. The chamber also considered Senate Executive Message No. 4 from the Committee on Confirmations. The Senate confirmed all nominees except number 54 in a 33-0 vote, then separately confirmed nominee 54 by a 30-3 vote. In debate on SB 392, the majority leader explained that the House removed a proposed vape tax increase to preserve the income tax reduction, while a senator from the 13th spoke about affordability concerns, tax relief, and urging action on gasoline prices; those remarks were ordered into the Journal. After the legislative business, the Senate received several introductions of guests and visitors in the galleries, including state police sergeants, family members of senators and pages, and the wife of the newest senator from Pleasants County. The Senate then agreed to recess until 5:30 p.m., with the Rules Committee scheduled to meet immediately after recess.